SSRIs/西酞普兰对卒中后认知功能障碍的影响

陈长宇; 陈康宁; 柳春雨; 段炜

您当前的位置：

首页 >

文章列表页 >

SSRIs/西酞普兰对卒中后认知功能障碍的影响

更新时间：2024-01-17

- SSRIs/西酞普兰对卒中后认知功能障碍的影响
- Influence of SSRIs(selective serotonin reuptake inhibitors)/citalopramon cognitive impairment in patients with stroke
- 重庆医科大学学报 2006年第2期页码：240-242
- 作者机构：
  
  1. 第三军医大学西南医院神经内科
  2. 第三军医大学西南医院神经内科,重庆,400038
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R749.1
- 纸质出版日期：2006，
扫描看全文
[1]陈长宇,陈康宁,柳春雨,段炜.SSRIs/西酞普兰对卒中后认知功能障碍的影响[J].重庆医科大学学报,2006(02):240-242+252.

CHEN Changyu, et al. Influence of SSRIs(selective serotonin reuptake inhibitors)/citalopramon cognitive impairment in patients with stroke[J]. Journal of Chongqing Medical University, 2006,(2):240-242.
[1]陈长宇,陈康宁,柳春雨,段炜.SSRIs/西酞普兰对卒中后认知功能障碍的影响[J].重庆医科大学学报,2006(02):240-242+252. DOI：

CHEN Changyu, et al. Influence of SSRIs(selective serotonin reuptake inhibitors)/citalopramon cognitive impairment in patients with stroke[J]. Journal of Chongqing Medical University, 2006,(2):240-242. DOI：

摘要

目的:观察选择性5-HT再摄取抑制剂类药物西酞普兰对患者卒中后认知功能障碍的影响。方法:所有患者为第三军医大学附属西南医院神经内科住院病人

应用简易精神状态量表筛选卒中后认知功能障碍的患者40例

随机分为治疗和对照组

在常规治疗的同时治疗组加西酞普兰片

为每天早餐后口服20mg

连用3个月。在治疗前和治疗后1月、3月使用简易精神状态量表

汉密尔顿抑郁量表

美国国立卫生院卒中量表

Barthel指数评定患者的功能。结果:治疗后治疗组患者的认知功能改善明显优于对照组（19.35±2.85

21.55±3.24

P<0.05）。结论:西酞普兰能改善患者卒中后认知功能障碍。

Abstract

Objective: To investigate the effect of early treatment with SSRIs/Citalopram on cognitive impairment in patients with stroke.Methods: A total of forty patients with cognitive impairment following stroke

in the Department of Neurology

Southwest Hospital of the Third Military Medical University

selected by the Mini-Mental State Examination

were randomly divided into treatment group and control group.All the patients received routine treatment

besides Citalopram were given to those in the treatment group.20mg Citalopram Hydrobromide Tablets would be given after breakfast everyday for 3 mouths?Patients in both groups were investigated with the Mini-Mental State Examination

Hamilton Rating Scale for Depression

National Institute of Health Stroke Scale and Barthel Index to examine the functions before and 1 and 3months after treatment respectively.Result: The improvement of cognitive function of patients in the treatment group was obviously superior to those in the control group(19.35±2.85

21.55±3.24

P<0.05).Conclusion: Citalopram can promote the recovery of cognitive impairment in patients with stroke.

关键词

选择性5-HT再摄取抑制剂西酞普兰认知功能障碍

Keywords

SSRIsCitalopramcognitive impairment

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

虚拟现实技术在阿尔茨海默病患者认知功能评估中的应用进展

脑小血管病与认知功能障碍

卒中后认知功能障碍